Published in Naunyn Schmiedebergs Arch Pharmacol on February 03, 2004
Salivary cortisol and prefrontal cortical thickness in middle-aged men: A twin study. Neuroimage (2010) 1.09
High-resolution imaging of brain 5-HT 1B receptors in the rhesus monkey using [11C]P943. Nucl Med Biol (2009) 1.03
Dose-dependent binding of AZD3783 to brain 5-HT1B receptors in non-human primates and human subjects: a positron emission tomography study with [11C]AZ10419369. Psychopharmacology (Berl) (2011) 0.86
The guinea pig forced swim test as a new behavioral despair model to characterize potential antidepressants. Psychopharmacology (Berl) (2007) 0.79
Repeated administration of the 5-HT(1B) receptor antagonist SB-224289 blocks the desensitisation of 5-HT(1B) autoreceptors induced by fluoxetine in rat frontal cortex. Naunyn Schmiedebergs Arch Pharmacol (2004) 0.76
Differential cytotoxicity responses by dog and rat hepatocytes to phospholipogenic treatments. J Toxicol (2013) 0.75
Current advances and trends in the treatment of depression. Trends Pharmacol Sci (1994) 3.49
Combined administration of a 5-hydroxytryptamine (5-HT)1D antagonist and a 5-HT reuptake inhibitor synergistically increases 5-HT release in guinea pig hypothalamus in vivo. J Neurochem (1996) 1.57
5-HT1 agonists reduce 5-hydroxytryptamine release in rat hippocampus in vivo as determined by brain microdialysis. Br J Pharmacol (1989) 1.35
Quantitative autoradiography of multiple 5-HT1 receptor subtypes in the brain of control or 5,7-dihydroxytryptamine-treated rats. J Neurosci (1986) 1.31
Effects of a selective 5-HT reuptake blocker, citalopram, on the sensitivity of 5-HT autoreceptors: electrophysiological studies in the rat brain. Naunyn Schmiedebergs Arch Pharmacol (1986) 1.22
Uptake inhibitors increase extracellular serotonin concentration measured by brain microdialysis. Life Sci (1994) 1.16
(-)-Propranolol blocks the inhibition of serotonergic dorsal raphe cell firing by 5-HT1A selective agonists. Eur J Pharmacol (1986) 1.03
The 5-HT 1A receptor agonist, 8-OH-DPAT, preferentially activates cell body 5-HT autoreceptors in rat brain in vivo. Naunyn Schmiedebergs Arch Pharmacol (1988) 1.02
Different effects on the responses of functional pre- and postsynaptic 5-HT1A receptors by repeated treatment of rats with the 5-HT1A receptor agonist 8-OH-DPAT. Neuropharmacology (1990) 1.00
Potentiation of the fluoxetine-induced increase in dialysate levels of serotonin (5-HT) in the frontal cortex of freely moving rats by combined blockade of 5-HT1A and 5-HT1B receptors with WAY 100,635 and GR 127,935. J Neurochem (1997) 0.94
Effect of a selective 5-HT reuptake inhibitor in combination with 5-HT1A and 5-HT1B receptor antagonists on extracellular 5-HT in rat frontal cortex in vivo. Br J Pharmacol (1997) 0.92
Simultaneous determination of dopamine, DOPAC and homovanillic acid. Direct injection of supernatants from brain tissue homogenates in a liquid chromatography--electrochemical detection system. J Chromatogr (1980) 0.90
Behavioral pharmacology of AR-A000002, a novel, selective 5-hydroxytryptamine(1B) antagonist. J Pharmacol Exp Ther (2003) 0.89
Application of [125I]iodocyanopindolol to measure 5-hydroxytryptamine1B receptors in the brain of the rat. J Pharmacol Exp Ther (1988) 0.86
Effects of selective h5-HT1B (SB-216641) and h5-HT1D (BRL-15572) receptor ligands on guinea-pig and human 5-HT auto- and heteroreceptors. Naunyn Schmiedebergs Arch Pharmacol (1997) 0.86
5-HT 1B/D receptor antagonists. Gen Pharmacol (1997) 0.86
Differential effects of 5-HT1B/1D receptor antagonists in dorsal and median raphe innervated brain regions. Eur J Pharmacol (1998) 0.83
Enhanced 5-HT metabolism and synthesis rate by the new selective r5-HT1B receptor antagonist, NAS-181 in the rat brain. Neuropharmacology (2000) 0.83
The ability of WAY100,635 to potentiate the neurochemical and functional actions of fluoxetine is enhanced by co-administration of SB224,289, but not BRL15572. Neuropharmacology (2000) 0.83
The forgotten 5-hydroxyindoleacetic acid. J Neurochem (1997) 0.82
Effects of the 5-HT1D receptor antagonist GR127935 on extracellular levels of 5-HT in the guinea-pig frontal cortex as measured by microdialysis. Neuropharmacology (1995) 0.82
The effects of GR127935, a putative 5-HT1D receptor antagonist, on brain 5-HT metabolism, extracellular 5-HT concentration and behaviour in the guinea pig. Neuropharmacology (1995) 0.82
Importance of h5-HT1B receptor selectivity for 5-HT terminal autoreceptor activity: an in vivo microdialysis study in the freely-moving guinea-pig. Neuropharmacology (1997) 0.81
Synergism between 5-HT1B/1D and 5-HT1A receptor antagonists on turnover and release of 5-HT in guinea-pig brain in vivo. Naunyn Schmiedebergs Arch Pharmacol (1999) 0.80
Stimulation of central 5-HT1D receptors causes hypothermia in the guinea-pig. J Psychopharmacol (1994) 0.80
5-HT1D receptors regulate 5-HT release in the rat raphe nuclei. In vivo voltammetry and in vitro superfusion studies. Neuropsychopharmacology (1995) 0.80
Failure to detect in vivo inverse agonism of the 5-HT(1B) receptor antagonist SB-224289 in 5-HT-depleted guinea-pigs. Naunyn Schmiedebergs Arch Pharmacol (2002) 0.75
Direct observation of individual endogenous protein complexes in situ by proximity ligation. Nat Methods (2006) 12.63
The F-box protein Skp2 participates in c-Myc proteosomal degradation and acts as a cofactor for c-Myc-regulated transcription. Mol Cell (2003) 3.87
c-Myc associates with ribosomal DNA and activates RNA polymerase I transcription. Nat Cell Biol (2005) 3.79
Characterizing proteins and their interactions in cells and tissues using the in situ proximity ligation assay. Methods (2008) 3.16
Myc represses differentiation-induced p21CIP1 expression via Miz-1-dependent interaction with the p21 core promoter. Oncogene (2003) 2.59
Cdk2 suppresses cellular senescence induced by the c-myc oncogene. Nat Cell Biol (2009) 1.99
The c-MYC oncoprotein, the NAMPT enzyme, the SIRT1-inhibitor DBC1, and the SIRT1 deacetylase form a positive feedback loop. Proc Natl Acad Sci U S A (2011) 1.90
Prevalence and underdiagnosis of COPD by disease severity and the attributable fraction of smoking Report from the Obstructive Lung Disease in Northern Sweden Studies. Respir Med (2005) 1.89
Ten-year cumulative incidence of COPD and risk factors for incident disease in a symptomatic cohort. Chest (2005) 1.61
Co-morbidity in mild-to-moderate COPD: comparison to normal and restrictive lung function. COPD (2011) 1.59
Prevalence of chronic obstructive pulmonary disease according to BTS, ERS, GOLD and ATS criteria in relation to doctor's diagnosis, symptoms, age, gender, and smoking habits. Respiration (2005) 1.55
Phosphorylation by Cdk2 is required for Myc to repress Ras-induced senescence in cotransformation. Proc Natl Acad Sci U S A (2009) 1.36
Seven-year cumulative incidence of COPD in an age-stratified general population sample. Chest (2006) 1.21
Myc is required for activation of the ATM-dependent checkpoints in response to DNA damage. PLoS One (2010) 1.07
Implication of the ubiquitin/proteasome system in Myc-regulated transcription. Cell Cycle (2003) 1.05
CDK-mediated activation of the SCF(FBXO) (28) ubiquitin ligase promotes MYC-driven transcription and tumourigenesis and predicts poor survival in breast cancer. EMBO Mol Med (2013) 0.99
A 20-year follow-up of a population study-based COPD cohort-report from the obstructive lung disease in Northern Sweden studies. COPD (2009) 0.93
Up-to-date on mortality in COPD - report from the OLIN COPD study. BMC Pulm Med (2012) 0.92
Cdk2: a key regulator of the senescence control function of Myc. Aging (Albany NY) (2010) 0.91
Combined IFN-gamma and retinoic acid treatment targets the N-Myc/Max/Mad1 network resulting in repression of N-Myc target genes in MYCN-amplified neuroblastoma cells. Mol Cancer Ther (2007) 0.89
Repression of in vivo growth of Myc/Ras transformed tumor cells by Mad1. Oncogene (2002) 0.88
TGF-beta enforces senescence in Myc-transformed hematopoietic tumor cells through induction of Mad1 and repression of Myc activity. Exp Cell Res (2009) 0.88
Sweet delivery - sugar translocators as ports of entry for antisense oligodeoxynucleotides in plant cells. Plant J (2007) 0.88
Evidence for involvement of 5-hydroxytryptamine(1B) autoreceptors in the enhancement of serotonin turnover in the mouse brain following repeated treatment with fluoxetine. Life Sci (2002) 0.87
Control of mild to moderate asthma over 1-year with the combination of salmeterol and fluticasone propionate. Respir Med (2005) 0.86
Tipping the balance: Cdk2 enables Myc to suppress senescence. Cancer Res (2010) 0.85
Drug-induced Myc-mediated apoptosis of cancer cells is inhibited by stress protein Hsp70. Int J Cancer (2007) 0.84
The world according to MYC. Conference on MYC and the transcriptional control of proliferation and oncogenesis. EMBO Rep (2007) 0.83
Effects of long-term administration of the 5-hydroxytryptamine1B receptor antagonist AR-A000002 to guinea pigs. Psychopharmacology (Berl) (2003) 0.81
Asthma control over 3 years in a real-life study. Respir Med (2008) 0.81
Modulation of neuronal glutamate transporter rEAAC1 mRNA expression in rat brain by amitriptyline. Brain Res Mol Brain Res (2004) 0.79
Increased incidence of parathyroid adenomas following X-ray treatment of benign diseases in the cervical spine in adult patients. Clin Endocrinol (Oxf) (2002) 0.78
Inhibition of the intrinsic but not the extrinsic apoptosis pathway accelerates and drives MYC-driven tumorigenesis towards acute myeloid leukemia. PLoS One (2012) 0.78
Mad 1 inhibits cell growth and proliferation but does not promote differentiation or overall survival in human U-937 monoblasts. Mol Cancer Res (2004) 0.78
Changes in extracellular 5-HIAA concentrations as measured by in vivo microdialysis technique in relation to changes in 5-HT release. Psychopharmacology (Berl) (2004) 0.78
Cellular senescence--a barrier against tumor development? Semin Cancer Biol (2011) 0.77
Decline in FEV1 in relation to incident chronic obstructive pulmonary disease in a cohort with respiratory symptoms. COPD (2007) 0.77
Rapid and long-lasting tolerance to clomethiazole-induced hypothermia in the rat. Eur J Pharmacol (2005) 0.76
A retrospective study of clinical usage of quetiapine XR and quetiapine IR in outpatients with schizophrenia in Denmark. Hum Psychopharmacol (2012) 0.76
Use of quetiapine XR and quetiapine IR in clinical practice for hospitalized patients with schizophrenia: a retrospective study. Ther Adv Psychopharmacol (2012) 0.76
Detection of breast cancer with mammography in the first screening round in relation to expected incidence in different age groups. Acta Oncol (2003) 0.75
Thyroid cancer after X-ray treatment of benign disorders of the cervical spine in adults. Acta Oncol (2002) 0.75
Functioning thyroid carcinomas--some historical aspects. Acta Oncol (2006) 0.75
Methods to study MYC-regulated cellular senescence. Methods Mol Biol (2013) 0.75
In vitro characterization of AR-A000002, a novel 5-hydroxytryptamine(1B) autoreceptor antagonist. Eur J Pharmacol (2004) 0.75
Failure to detect in vivo inverse agonism of the 5-HT(1B) receptor antagonist SB-224289 in 5-HT-depleted guinea-pigs. Naunyn Schmiedebergs Arch Pharmacol (2002) 0.75
Counteraction of the rapid tolerance to 8-hydroxy-2-(di-n-propylamino)tetralin-induced hypothermia in rats by activation of the GABAA receptor-chloride channel complex. Pharmacol Toxicol (2002) 0.75